India has purchased 500 million doses of the Oxford University-AstraZeneca vaccine candidate, one billion from the US company Novavax and 100 million doses of the Sputnik V candidate from Russia’s Gamaleya Research Institute.
India Biggest Buyer of Covid-19 Vaccine with 1.6 Bn Doses, Experts Say This Could Cover 60% Population